Associations Between Estimated Pulse Wave Velocity and Five-Year All-Cause Mortality in Patients with Atherosclerotic Cardiovascular Disease with and without Standard Modifiable Risk Factors: Evidence From NHANES 1999-2016

References

• Aboyans V; Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/s0140-6736(14)61682-2
   PubMed Web of Science ®Google Scholar
• Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124(3):314–323. doi:10.1161/circulationaha.111.018820
   PubMed Web of Science ®Google Scholar
• Barquera S, Pedroza-Tobías A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46(5):328–338. doi:10.1016/j.arcmed.2015.06.006
   PubMed Web of Science ®Google Scholar
• Wilson PW, Rb D, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847. doi:10.1161/01.cir.97.18.1837
   PubMed Web of Science ®Google Scholar
• Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898–904. doi:10.1001/jama.290.7.898
   PubMed Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. doi:10.1093/eurheartj/ehab484
   PubMed Web of Science ®Google Scholar
• Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795–808. doi:10.1016/s0140-6736(19)32008-2
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
   PubMed Web of Science ®Google Scholar
• Figtree GA, Vernon ST. Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries. Cardiovasc Res. 2021;117(6):e76–e78. doi:10.1093/cvr/cvab145
   PubMed Web of Science ®Google Scholar
• Escudero-Sánchez G, Rico-Martín S, Sánchez-Bacaicoa C, et al. Optimal control of all modifiable vascular risk factors among patients with atherosclerotic disease. A real-life study. Curr Probl Cardiol. 2023;48(3):101530. doi:10.1016/j.cpcardiol.2022.101530
   PubMed Web of Science ®Google Scholar
• Mahtta D, Khalid U, Misra A, Samad Z, Nasir K, Virani SS. Premature atherosclerotic cardiovascular disease: what have we learned recently? Curr Atheroscler Rep. 2020;22(9):44. doi:10.1007/s11883-020-00862-8
   PubMed Web of Science ®Google Scholar
• Vikulova DN, Grubisic M, Zhao Y, et al. Premature atherosclerotic cardiovascular disease: trends in incidence, risk factors, and sex-related differences, 2000 to 2016. J Am Heart Assoc. 2019;8(14):e012178. doi:10.1161/jaha.119.012178
   PubMed Web of Science ®Google Scholar
• Figtree GA, Vernon ST, Hadziosmanovic N, et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet. 2021;397(10279):1085–1094. doi:10.1016/s0140-6736(21)00272-5
   PubMed Web of Science ®Google Scholar
• Park SM, Seo HS, Lim HE, et al. Assessment of arterial stiffness index as a clinical parameter for atherosclerotic coronary artery disease. Circ J. 2005;69(10):1218–1222. doi:10.1253/circj.69.1218
   PubMed Web of Science ®Google Scholar
• Boutouyrie P, Bruno RM. The clinical significance and application of vascular stiffness measurements. Am J Hypertens. 2019;32(1):4–11. doi:10.1093/ajh/hpy145
   PubMed Web of Science ®Google Scholar
• Lacolley P, Regnault V, Segers P, Laurent S. Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease. Physiol Rev. 2017;97(4):1555–1617. doi:10.1152/physrev.00003.2017
   PubMed Web of Science ®Google Scholar
• Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American heart association. Hypertension. 2015;66(3):698–722. doi:10.1161/hyp.0000000000000033
   PubMed Web of Science ®Google Scholar
• Greve SV, Blicher MK, Kruger R, et al. Estimated carotid-femoral pulse wave velocity has similar predictive value as measured carotid-femoral pulse wave velocity. J Hypertens. 2016;34(7):1279–1289. doi:10.1097/hjh.0000000000000935
   PubMed Web of Science ®Google Scholar
• Hametner B, Wassertheurer S, Mayer CC, Danninger K, Binder RK, Weber T. Aortic pulse wave velocity predicts cardiovascular events and mortality in patients undergoing coronary angiography: a comparison of invasive measurements and noninvasive estimates. Hypertension. 2021;77(2):571–581. doi:10.1161/hypertensionaha.120.15336
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Terentes-Printzios D, Laurent S, et al. Association of estimated pulse wave velocity with survival: a secondary analysis of SPRINT. JAMA Network Open. 2019;2(10):e1912831. doi:10.1001/jamanetworkopen.2019.12831
   PubMed Web of Science ®Google Scholar
• Skipina TM, Patel N, Upadhya B, Soliman EZ. Cannabis use is associated with prevalent coronary artery disease. Am J Med Sci. 2022;364(3):304–308. doi:10.1016/j.amjms.2022.04.005
   PubMed Web of Science ®Google Scholar
• Sule S, Fontaine K. Coronary artery disease in adults with a history of juvenile arthritis. Arthritis Care Res. 2020;72(12):1790–1793. doi:10.1002/acr.24087
   Web of Science ®Google Scholar
• Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. doi:10.1186/s12933-021-01268-9
   PubMed Web of Science ®Google Scholar
• Liu C, Lai W, Zhao M, Zhang Y, Hu Y. Association between the composite dietary antioxidant index and atherosclerotic cardiovascular disease in postmenopausal women: a cross-sectional study of NHANES data, 2013–2018. Antioxidants. 2023;12(9):1740. doi:10.3390/antiox12091740
   Web of Science ®Google Scholar
• Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010;31(19):2338–2350. doi:10.1093/eurheartj/ehq165
   PubMed Web of Science ®Google Scholar
• Harris ST, Zeng X, Ford L. International classification of diseases, 10th Revision: it’s coming, ready or not. Health Care Manag. 2011;30(3):227–235. doi:10.1097/HCM.0b013e318225e0a2
   Google Scholar
• Yang X, Li J, Hu D, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese Population: the China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134(19):1430–1440. doi:10.1161/circulationaha.116.022367
   PubMed Web of Science ®Google Scholar
• Yi T, Gao L, Fan F, et al. Association between pulse wave velocity and the 10-year risk of atherosclerotic cardiovascular disease in the Chinese population: a community-based study. J Clin Hypertens. 2023;25(3):278–285. doi:10.1111/jch.14642
   Web of Science ®Google Scholar
• He XW, Park J, Huang WS, et al. Usefulness of estimated pulse wave velocity for identifying prevalent coronary heart disease: findings from a general Chinese population. BMC Cardiovasc Disord. 2022;22(1):9. doi:10.1186/s12872-022-02456-5
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Mf O, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31(15):1865–1871. doi:10.1093/eurheartj/ehq024
   PubMed Web of Science ®Google Scholar
• Mazhar J, Figtree G, Vernon ST, et al. Progression of coronary atherosclerosis in patients without standard modifiable risk factors. Am J Prev Cardiol. 2020;4:100116. doi:10.1016/j.ajpc.2020.100116
   PubMedGoogle Scholar
• Leipsic J, Taylor CM, Grunau G, et al. Cardiovascular risk among stable individuals suspected of having coronary artery disease with no modifiable risk factors: results from an international multicenter study of 5262 patients. Radiology. 2013;267(3):718–726. doi:10.1148/radiol.13121669
   PubMed Web of Science ®Google Scholar
• Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636–646. doi:10.1016/j.jacc.2013.09.063
   PubMed Web of Science ®Google Scholar
• Greve SV, Blicher MK, Kruger R, et al. Elevated estimated arterial age is associated with metabolic syndrome and low-grade inflammation. J Hypertens. 2016;34(12):2410–2417. doi:10.1097/hjh.0000000000001083
   PubMed Web of Science ®Google Scholar
• Chen C, Bao W, Chen C, Chen L, Wang L, Gong H. Association between estimated pulse wave velocity and all-cause mortality in patients with coronary artery disease: a cohort study from NHANES 2005–2008. BMC Cardiovasc Disord. 2023;23(1):412. doi:10.1186/s12872-023-03435-0
   PubMed Web of Science ®Google Scholar
• Laugesen E, Olesen KKW, Peters CD, et al. Estimated pulse wave velocity is associated with all-cause mortality during 8.5 years follow-up in patients undergoing elective coronary angiography. J Am Heart Assoc. 2022;11(10):e025173. doi:10.1161/jaha.121.025173
   PubMed Web of Science ®Google Scholar
• Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016;388(10060):2665–2712. doi:10.1016/s0140-6736(16)31134-5
   PubMed Web of Science ®Google Scholar
• Mozos I, Jianu D, Gug C, Stoian D. Links between high-sensitivity c-reactive protein and pulse wave analysis in middle-aged patients with hypertension and high normal blood pressure. Dis Markers. 2019;2019:2568069. doi:10.1155/2019/2568069
   PubMed Web of Science ®Google Scholar
• Climie RE, Alastruey J, Mayer CC, et al. Vascular ageing: moving from bench towards bedside. Eur J Prev Cardiol. 2023;30(11):1101–1117. doi:10.1093/eurjpc/zwad028
   PubMed Web of Science ®Google Scholar
• Seeland U, Nemcsik J, Lønnebakken MT, et al. Sex and gender aspects in vascular ageing - focus on epidemiology, pathophysiology, and outcomes. Heart Lung Circ. 2021;30(11):1637–1646. doi:10.1016/j.hlc.2021.07.006
   PubMed Web of Science ®Google Scholar